Product Images Xcopri

This appears to be a table showing the proportion of patients and their reduction in seizure frequency from baseline for two groups - DPlacebo and EXCOPRI 200 mg. The table seems incomplete as there is no data available under the four different proportion of patients categories (0t<25%, 25t0<50%, S0t<7%, 75t05100%). Hence the information available is limited and not enough to draw any useful conclusion or analysis.*

This is a medication called XCOPRI, which comes in a bottle with 30 tablets and requires a prescription. Patients are required to receive an accompanying medication guide. The recommended dosage should be determined by a prescribing physician, and the tablets should be swallowed whole with liquid and not crushed or chewed. The medication should be kept out of reach of children and stored at controlled room temperatures. The manufacturer is SK Life Science, Inc., located in Paramus, NJ. The medication can be reached at 1-866-657-5574.*

XCOPRI (cenobamate tablets) is a prescription medication available in the form of 50mg tablets. Each patient is required to receive an accompanying medication guide. It should be swallowed whole with liquid and not crushed or chewed. It should be kept out of reach of children and stored at controlled room temperature between 20°C to 25°C (68°F to 77°F), with excursions allowed between 15°C to 30°C (59°F to 86°F). This medication is manufactured for SK Life Science, Inc. and is available in a professional sample format for medical practitioners only.*

NDC 71699-100-30 is a prescription medication called XCOPRI containing cenobamate tablets. The medication is supplied in a bottle of 30 tablets and requires an accompanying medication guide for each patient. The recommended dosage is available in the prescribing information and should be swallowed whole with liquid, without crushing or chewing. It should be kept out of reach of children and stored at a controlled room temperature between 20°C to 25°C (68°F to 77°F) with permissible excursions between 15°C to 30°C (59°F to 86°F). The medication is manufactured for SK Life Science, Inc. in NJ, and for additional information and inquiries, one can contact 1-866-657-5574.*

XCOPRI is a prescription medication (NDC 71699-150-30) used to treat seizures. The recommended dosage and instructions for use are provided in the prescribing information. The tablets should be swallowed whole with liquid and stored at room temperature. Each patient should receive an accompanying medication guide. XCOPRI is manufactured by SK Life Science, Inc. in Paramus, NJ.*

NDC 71699-200-30 is a prescription medication called XCOPRI, which comes in the form of tablets. Patients who take XCOPRI should follow the recommended dosage information provided in the prescribing information. It should be swallowed whole with liquid and should not be crushed or chewed. Each patient is required to receive an accompanying medication guide. The tablets should be kept out of reach of children and stored at a controlled room temperature between 20°C to 25°C (68°F to 77°F) with excursions allowed between 15°C to 30°C (59°F to 86°F). XCOPRI is manufactured for SK Life Science, Inc. in Paramus, NJ. For more information, patients can call 1-866-657-5574.*

This appears to be a medication package containing two dosages of a drug called cenobamate. The instructions indicate that patients should take 12.5mg once a day for two weeks, then switch to a 25mg dosage for the next two weeks. It is noted that each patient needs to receive an accompanying medication guide. The package contains 28 tablets total, with 14 tablets of each dosage. The drug appears to be prescription-only and has a specific National Drug Code (NDC). However, due to the lack of clear information, it is difficult to provide a more detailed description.*

This text is the label of a medication package called "Cenobamate Tablets TITRATION PACK". It includes instructions on how to take the medication and the number of tablets included in the package. The manufacturer's information and contact number are also provided on the label.*

This is a medication guide for a TITRATION PACK consisting of 150mg and 200mg tablets taken once daily. The pack contains 14 tablets of each dose and the medication should be taken for four weeks in total. Each patient is required to receive an accompanying medication guide. The medication is manufactured for SK Life Science, Inc. This is a prescribed medication and is only available with a prescription.*

XCOPRI is a medication available in tablet form with 150mg or 200mg per tablet. It should be taken orally, swallowed whole with liquid, and not crushed or chewed. The initial dose is 150mg once daily for two weeks, followed by a dose of 200mg once daily for two weeks. It can be taken with or without food. The tablet should be stored at room temperature, between 20°C to 25°C (68°F to 77°F), and out of reach of children. The ingredient of each tablet is cenobamate. Dosage information can be found in the prescribing information.*

XCOPRI is a medication that comes in tablets with either 200 mg or 50 mg of CENOBAMATE. The tablets should be taken orally once daily and may be taken with or without food, but should not be crushed or chewed. They should be kept at a controlled room temperature between 20°C to 25°C (68°F to 77°F) with excursions allowed between 15°C to 30°C (59°F to 86°F). XCOPRI should be taken according to the prescribing information, and the medication should be kept out of reach of children. The provided text also includes a visual guide on how to push through Flip over and Push pill half-circle peel tab through foil.*

XCOPRI is a medication that comes in tablets of 200 mg or 150 mg. The recommended dose is taking these tablets orally once daily for four weeks, with or without food. The tablets should not be crushed or chewed and must be swallowed whole with liquid. To access the tablet, push through flip over and push a pill through the half-circle peel tab through foil. XCOPRI should be stored at room temperature and out of reach of children. Each tablet of XCOPRI has CENOBAMATE as the active ingredient. No additional information is available from the text.*

XCOPRI is a medication containing Cenobamate and it's recommended to take 150 mg and 100 mg orally once daily for four weeks, with or without food. The tablets should be swallowed whole with liquid and not be crushed or chewed. It's important to keep the medication out of reach of children and store them at controlled room temperature between 20°C to 25°C (68°F to 77°F), with occasional excursions allowed between 15°C to 30°C (59°F to 86°F). For recommended dosage, refer to prescribing information. The text also includes an illustration that shows how to push through a flip-over and push pill half-circle peel tab through foil.*

This is a Professional Sample, not for sale, containing a titration pack with 12.5 mg and 25 mg tablets to be taken once daily for two weeks each. The pack should include an accompanying medication guide for each patient. The manufacturer is SK Life Science, Inc., and the pack has an NDC code of 7 699-999-99. This is a prescription-only medication containing Cenobamate tablets.*